Showing 1,681 - 1,700 results of 144,150 for search '(( i we decrease ) OR ( 5 ((((step decrease) OR (nn decrease))) OR (a decrease)) ))', query time: 1.99s Refine Results
  1. 1681

    Snapshotting the Excited-State Planarization of Chemically Locked <i>N</i>,<i>N</i>′‑Disubstituted Dihydrodibenzo[<i>a</i>,<i>c</i>]phenazines by Wei Chen (23863)

    Published 2017
    “…Accordingly, a series of <b>DPAC-<i>n</i></b> (<i>n</i> = 1–8) derivatives were synthesized, in which <i>n</i> correlates with the alkyl length, such that the strength of the spatial constraint decreases as <i>n</i> increases. …”
  2. 1682

    The effects of losartan on cytomegalovirus infection in human trabecular meshwork cells by Jin A. Choi (559035)

    Published 2019
    “…TM cells treated with TGF-β1 along with the presence of losartan for 48 hours showed marked decrease in the expression of α-smooth muscle actin (SMA), lysyl oxidase (LOX), connective tissue growth factor (CTGF), fibronectin and collagen-1A, compared with cells treated with TGF-β1 alone. …”
  3. 1683

    Polymorphisms in <i>CYP1B1</i>, <i>CYP3A5</i>, <i>GSTT1</i>, and <i>SULT1A1</i> Are Associated with Early Age Acute Leukemia by Bruno Almeida Lopes (740876)

    Published 2015
    “…Using data from the Brazilian Collaborative Study Group of Infant Acute Leukemia (2000–2012), 350 cases and 404 age-matched controls and 134 mothers of cases and controls were genotyped to explore polymorphisms in genes of the estrogen metabolism pathway: <i>CYP1B1</i> (c.1294C>G, rs1056836), <i>CYP3A4</i> (c.-392A>G, rs2740574), <i>CYP3A5</i> (c.219-237G>A, rs776746), <i>GSTM1/GSTT1</i> deletions, and <i>SULT1A1</i> (c.638G>A, rs9282861; and c.667A>G, rs1801030). …”
  4. 1684
  5. 1685

    Decreased activity of FASII favors the cold growth of the <i>ΔcshA</i> strain. by Vanessa Khemici (814639)

    Published 2020
    “…<i>fapR</i> mRNA levels were quantified by RT-qPCR using 16S rRNA as reference gene on total RNAs extracted from <i>wt</i> strain (PR01), <i>ΔcshA</i> strain (PR01-ΔcshA), and suppressor strains <i>ΔcshA/accC</i><sup><i>M385V</i></sup> (C51), <i>ΔcshA/accC</i><sup><i>T183I</i></sup> (sup30), <i>ΔcshA/accD</i><sup><i>F253V</i></sup> (sup17), <i>ΔcshA/accD</i><sup><i>A164V</i></sup> (sup16), <i>ΔcshA/birA</i><sup><i>D320F-FsX28</i></sup> (C58), <i>ΔcshA/birA</i><sup><i>R280stop</i></sup> (sup1) and <i>ΔcshA/bioY</i><sup><i>P123R-FsX1</i></sup> (C66), all at exponential growth phase in MH medium at 25°C. n = 5 for <i>ΔcshA</i>, <i>4 for wt</i> and 3 for all others. …”
  6. 1686

    Trial profile. by Chanel Avenant (409756)

    Published 2024
    “…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …”
  7. 1687
  8. 1688

    Adverse events in low-dose naltrexone arm. by Judith I. Tsui (5983160)

    Published 2024
    “…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”
  9. 1689

    CONSORT flow diagram. by Judith I. Tsui (5983160)

    Published 2024
    “…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”
  10. 1690

    Adverse events in placebo arm. by Judith I. Tsui (5983160)

    Published 2024
    “…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”
  11. 1691

    Adverse events in gabapentin arm. by Judith I. Tsui (5983160)

    Published 2024
    “…Pain interference decreased for all three arms. Mean differences in change in pain interference for gabapentin vs. placebo, and naltrexone vs. placebo was 0.16 (95% CI -1.38, 1.71; p = 0.83) and 0.40 (95% CI -1.18, 1.99; p = 0.83), respectively.…”
  12. 1692

    The raw data for Fig 5B. by Hongjoo An (21703199)

    Published 2025
    “…Consistently, <i>Pick1</i>, a gene that is near the <i>Sox10</i> TAD border, is also under the transcriptional control of Sox10-E1 and Sox10-E2. …”
  13. 1693

    Identifying Loci Contributing to Natural Variation in Xenobiotic Resistance in <i>Drosophila</i> by Michael A. Najarro (831657)

    Published 2015
    “…<i>Cyp12d1</i> is implicated by QTL mapped in both panels of DSPR RILs, is significantly upregulated in the presence of caffeine, and RNAi knockdown robustly decreases caffeine tolerance. …”
  14. 1694
  15. 1695
  16. 1696
  17. 1697
  18. 1698

    Juvenile demyelination induces a loss of functional autapses. by Sara Hijazi (21656615)

    Published 2025
    “…<p><b>A</b>. <i>Upper panel</i>. Example traces (average of 8 sweeps) of unitary autaptic inhibitory postsynaptic currents triggered by voltage steps from holding potential of -−70 mV to 0 mV in PV interneuron (fast inward Na+ currents were partially removed), which can be blocked by gabazine (gray). …”
  19. 1699
  20. 1700